Digg It - Finance

As the credit card market becomes more competitive than ever, banks and lending institutions are coming up with new marketing and financial strateg

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ies to obtain more customers. One of those strategies used to acquire more customers is through the use of a cash back credit card.

By definition,

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

those are credit cards that will return a fixed percentage of cash back to the customer according to the amount of purchases charged on the credit

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ard. Usually, the cash back rebate is typically anywhere between 1 to 2% and is computed within a given time frame. Therefore, cash back credit c

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

rds might result in a good saving tool if used properly and conscientiously.

Let’s assume that a given person will use his/her credit card and wil

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

also carry a monthly card balance. If the ongoing interest rate is very high, the finance charges will or than likely offset any of the savings ga

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ined from the cash rebates. On the other hand, if the card balance is paid in full at the end of every grace period, the cash back rebates earned f

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

om the credit card will usually end up earning the cardholder money back and sometimes a significant amount depending on how often the card is used

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

Cash back credit cards will payout the cash rebates earned either by crediting the actual earned rebate back against the existing card balance or

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

will pay the cardholder with a rebate check, usually in $50 to $100 increments.

With the notion of accumulating cash with card purchases, people w

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ll psychologically tend to use their credit cards more than other payment options. Very often, cardholders will set a specific time frame for thei

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

r card purchase activities in order to accumulate the most cash rebates possible. As more and more companies accept credit cards, cardholders are b

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

coming more and more comfortable with using their respective cards to pay virtually everything including utility bills, mortgages and rent payments

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

With a 1% to as high as a 5% cash back bonus on all purchases, cardholders anticipate some hefty savings from a cash back credit card.

Not surpr

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

singly, cash back credit cards are very popular with consumers. But cardholders must be wary of using them correctly, if they wish to derive maximu

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

benefit. Banks and credit card issuers typically design the cards to maximize their own profit not the consumers profit because card issuers anti

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

cipate the cards will not be used efficiently by some, if not many of the cardholders utilizing these cards.

Cash back credit cards are among the

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

any financial tools that can be truly rewarding for cardholders that use the cards effectively and look beyond just the pure attraction of receivin

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

cash back. If cardholders are vigilante about paying off their card balances each and every month, they can potentially rack up significant saving

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

from a cash back credit card. But if not, they might end up paying out significantly more in finance charges over time than their old credit card

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/92027/diggit-Cash-Back-Credit-Card-How-Rewarding-Is-It.html">Cash Back Credit Card: How Rewarding Is It?</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/92027/diggit-Cash-Back-Credit-Card-How-Rewarding-Is-It.html]Cash Back Credit Card: How Rewarding Is It?[/url]

Customer service isn't just a department, like accounting, it's what your business does to attract, retain and please your customers in totality. How you think about and treat your customers can make or break your business, or even worse give your competitors an advantage over you.

Building relationships with various types of people is important for networking both personally and professionally. You should take networking seriously because it can be a real asset for you and your organization. For many organizations, networking is a key component for generating new customers. This especially holds true if you work in business development or sales. Regardless of your role, you should always be selling your organization because you may be able to find new customers or build new partnerships, which could lead to new sales.

Yahoo's nearly year long flirtations with Facebook have apparently come to nothing. Recently Facebook valued itself at over 8 billion dollars and in the same breath claimed it was not for sale. This hefty price may simply be posturing to get a better deal, from Yahoo or some other major corporation with money to burn. Why all the interest in this, another member of the social networking craze?

Tags

Links

Digg It - Cash Back Credit Card: How Rewarding Is It?

Related Articles: